Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Sarcopenia might function as an indicator for frailty, and as such as a risk factor for the development of postoperative complications. The aim of this study was to meta‐analyse the relation between preoperative sarcopenia and the development of severe postoperative complications in patients undergoing oncological surgery.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>PubMed and Embase databases were systematically searched from inception until May 2018. Included were studies reporting on the incidence of severe postoperative complications and radiologically determined preoperative sarcopenia. Studies reporting the skeletal muscle as a continuous variable only were excluded. Data were extracted independently by two reviewers. Random effect meta‐analyses were applied to estimate the pooled odds ratio (OR) with 95% confidence intervals (95% CI) for severe postoperative complications, defined as Clavien‐Dindo grade ≥3, including 30‐day mortality. Heterogeneity was evaluated with <i>I</i><sup>2</sup> testing. Analyses were performed overall and stratified by measurement method, tumour location and publication date. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>A total of 1924 citations were identified, and 53 studies (14 295 patients) were included in the meta‐analysis. When measuring the total skeletal muscle area, 43% of the patients were sarcopenic, versus 33% when measuring the psoas area. Severe postoperative complications were present in 20%, and 30‐day mortality was 3%. Preoperative sarcopenia was associated with an increased risk of severe postoperative complications (OR<sub>pooled</sub>: 1.44, 95% CI: 1.24–16.8, <i>P</i><0.001, <i>I</i><sup>2</sup>=55%) and 30‐day mortality (OR<sub>pooled</sub>: 2.15, 95% CI: 1.46–3.17, <i>P</i><0.001, <i>I</i><sup>2</sup>=14%). A low psoas mass was a stronger predictor for severe postoperative complications compared with a low total skeletal muscle mass (OR<sub>pooled</sub>: 2.06, 95% CI: 1.37–3.09, OR<sub>pooled</sub>: 1.32, 95% CI: 1.14–1.53, respectively) and 30‐day mortality [OR<sub>pooled</sub>: 6.17 (95% CI: 2.71–14.08, OR<sub>pooled</sub>: 1.80 (95% CI: 1.24–2.62), respectively]. The effect was independent of tumour location and publication date. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>The presence of low psoas mass prior to surgery, as an indicator for sarcopenia, is a common phenomenon and is a strong predictor for the development of postoperative complications. The presence of low total skeletal muscle mass, which is even more frequent, is a less informative predictor for postoperative complications and 30‐day mortality. The low heterogeneity indicates that the finding is consistent over studies. Nevertheless, the value of sarcopenia relative to other assessments such as frailty screening is not clear. Research is needed in order to determine the place of sarcopenia in future preoperative risk stratification.</p></section>

Measurement of muscle quantity/quality has additional predictive value for postoperative complications and long-term survival after gastrectomy for gastric cancer in patients with probable sarcopenia as defined by the new EWGSOP2 consensus: Analysis from a large-scale prospective study

Prognostic Value of Sarcopenia in Patients with Rectal Cancer: A Meta-Analysis.

Preoperative Computed Tomography-Assessed Skeletal Muscle Index is a Novel Prognostic Factor in Patients with Hepatocellular Carcinoma Following Hepatectomy: a Meta-Analysis.

Sarcopenia is Associated with Perioperative Outcomes in Gastric Cancer Patients Undergoing Gastrectomy

Sarcopenia predicts postoperative complications and survival in colorectal cancer patients with GLIM-defined malnutrition: Analysis from a prospective cohort study

Sarcopenia As a Predictor of Poor Surgical and Oncologic Outcomes after Abdominal Surgery for Digestive Tract Cancer: A Prospective Cohort Study

Highlighting sarcopenia management for promoting surgical outcomes in esophageal cancers: Evidence from a prospective cohort study

Pre-operative Assessment of Muscle Mass to Predict Surgical Complications and Prognosis in Patients With Endometrial Cancer

Prognostic value of preoperative sarcopenia in gastric cancer: A 10-year follow-up study

Predictive Value of a New Muscle Parameter in Patients with Resectable Gastric Cancer: A Pooled Analysis of Three Prospective Trials

Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients following gastrectomy

Effect of Saropenia on Clinical Prognosis of Gastric Cancer Patients: A Prospective Cohort Study

Cachexia Versus Sarcopenia in Clinical Characteristics and Prognostic Value After Radical Gastrectomy for Gastric Cancer: A Large-Scale Prospective Study

Factors That Improve Chest Computed Tomography-Defined Sarcopenia Prognosis in Advanced Non-Small Cell Lung Cancer

Low skeletal muscle mass and postoperative morbidity in surgical oncology: a systematic review and meta‐analysis

Association of sarcopenia, as defined based on the skeletal muscle index, with mortality and morbidity after cardiac surgery: a retrospective cohort study

Sarcopenia Predicts Postoperative Complications and Survival of Colorectal Cancer Patients Undergoing Radical Surgery

Computed Tomography–Quantified Body Composition Predicts Short-Term Outcomes after Gastrectomy in Gastric Cancer

Is the measurement of sarcopenia associated with oncological disease in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?

Muscle loss 6 months after surgery predicts poor survival of patients with non-metastatic colorectal cancer

Prevalence of Sarcopenia and Its Impact on Postoperative Outcome in Patients with Crohn's Disease Undergoing Bowel Resection.